S

Spyre Therapeutics

Clinical-stage biotech antibodies for IBD

Director Regulatory Affairs

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • A bachelor's degree with 8–10 years of experience in pharmaceutical regulatory affairs and/or related disciplines, or an equivalent combination of relevant education, training, and experience.
  • A proven track record of successfully managing complex regulatory submissions.
  • Proven experience managing clinical trial applications in the United States and globally.
  • Strong knowledge of global pharmaceutical regulations and guidelines, including FDA, EMA, and ICH requirements.
  • Proficiency in medical and/or technical writing, including authoring or contributing to documents such as Module 2 and 3 summaries, DSURs, safety reports, investigational brochures, clinical trial protocols, clinical trial reports, and/or IMPDs.
  • Proficiency in regulatory affairs software and document management systems.
  • Ability to meet deadlines and adapt to changing priorities.

Responsibilities

  • Develop and implement regulatory strategies that enable the company’s clinical trials and marketing applications.
  • Stay current with evolving regulatory requirements and industry trends and advise the company on regulatory expectations.
  • Prepare, review, and submit regulatory applications and dossiers to health authorities, including the FDA, EMA, PMDA, and other global regulatory agencies, ensuring timely and successful approvals.
  • Plan meeting strategy, lead the development of briefing materials, capture action items, and support the team in implementing meeting strategy.
  • Represent the company in regulatory interactions and maintain effective communication with regulatory agencies, responding to inquiries and requests.
  • Communicate regulatory agency interactions and guidance to Regulatory Affairs leadership and cross-functional teams.
  • Identify potential regulatory risks and proactively develop mitigation strategies.
  • Monitor regulatory landscape changes and assess their impact on company products.
  • Keep abreast of new and evolving regulations, guidelines, and best practices in the pharmaceutical industry and adapt company strategies accordingly.
  • Collaborate with Pre-clinical Research & Development, Clinical Development, Technical Operations, Legal, and Quality and Compliance to integrate regulatory considerations into product development.
  • Contribute to the development and management of the regulatory affairs budget for assigned projects, ensuring cost-effective use of resources while maintaining high-quality regulatory activities.
  • Act as the overall lead of global regulatory applications for one or more drug candidates and lead submissions of original investigational new drug and clinical trial applications.
  • Plan and prepare for meetings with global health authorities, including FDA Type C and EOP2 meetings and EMA scientific advice, and support live discussions.
  • Support development of other assets for which the role is not the overall lead and contribute to development of Regulatory Department processes.

Desired Qualifications

  • Experience with CMC regulatory matters, devices such as pre-filled syringes and/or auto-injectors, and/or diagnostics such as companion diagnostics.

About the Company

Spyre Therapeutics

Clinical-stage biotech antibodies for IBD

Spyre Therapeutics develops long-acting antibody therapies for inflammatory bowel disease (IBD), targeting ulcerative colitis and Crohn’s disease with programs such as anti-α4β7 and anti-TL1A. These antibodies are designed to inhibit immune pathways in the gut to reduce inflammation and are built for durable effects, aiming for patient-friendly dosing and potential combo-therapy use. Unlike some peers, Spyre focuses on best-in-class antibodies with durability and a diversified pipeline, shifting away from its past enzyme programs toward immunology-driven treatments for large GI markets. The company aims to discover, develop, and potentially commercialize antibody therapies that address unmet needs in IBD and improve long-term patient outcomes.

Company size
51-200
Company stage
IPO
Headquarters
Waltham, MA
Founded
2023

Recently Posted Jobs

Explore more opportunities at Spyre Therapeutics

See more jobs